Evidence map›Paper›PMID 19389235›Full record

ArticleJournal of translational medicine2009

Alterations in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis.

Leo Jeng, Alexandra V Yamshchikov, Suzanne E Judd, Henry M Blumberg, Gregory S Martin, Thomas R Ziegler, Vin Tangpricha

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in Journal of translational medicine, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 184 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
184citing papers in PubMed, 5 pooled it
20.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01372995 phase2completednot on this mapstarted 2011, after this paper: background citation

High-Dose Vitamin D and Antimicrobial Peptide Expression in Lung Failure

TypeinterventionalSponsorEmory UniversityRan2011 to 2014Enrolled31ConditionsRespiratory FailureArmsEnteral Vitamin D3 50,000 IU, Enteral Vitamin D3 100,000IU, Inactive substance
NCT02138591 phase3withdrawnnot on this mapstarted 2016, after this paper: background citation

Therapeutic Benefit of Preoperative Supplemental Vitamin D in Patients Undergoing Major Surgical Procedures.

TypeinterventionalSponsorUniversity of Missouri, Kansas CityRan2016 to 2016Enrolled0ConditionsVitamin d DeficiencyArmsBlood draw pre-operatively, Blood draw post-operative Day 1, Blood draw post-operative Day 2
3 · Its place in the literature

Who cites it

184 citing papers in PubMed, 5 syntheses or guidelines pooled it, 439 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. High-Dose Vitamin DJPEN. Journal of parenteral and enteral nutrition · 2018
    Trial
  11. Trial
  12. Impact of high-dose vitamin DNutrition (Burbank, Los Angeles County, Calif.) · 2017
    Trial
  13. Trial
  14. Trial
  15. Free 25-Hydroxyvitamin D Concentrations in Cystic Fibrosis.The American journal of the medical sciences · 2015
    Trial
  16. Trial
  17. Trial
  18. Trial
  19. Trial
  20. Trial

124 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Leo JengDivision of Endocrinology, Diabetes & Lipids, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA. jengleo@gmail.com
Alexandra V Yamshchikov
Suzanne E Judd
Henry M Blumberg
Gregory S Martin
Thomas R Ziegler
Vin Tangpricha
Emory University · US

Funding

Atlanta Clinical and Translational Science Institute (ACTSI) RenewalUL1TR000454 · NCATS · EMORY UNIVERSITY · PI STEPHENS, DAVID S · 2012 to 2016
$25.8M
ENDOCRINOLOGY, METABOLISM, AND DIABETEST32DK007298 · NIDDK · EMORY UNIVERSITY · PI PACIFICI, ROBERTO · 1986 to 2014
$3.2M
Patient Oriented Research in Clinical NutritionK24RR023356 · NCRR · EMORY UNIVERSITY · PI ZIEGLER, THOMAS R · 2007 to 2011
$839k
Role of T-cells in Osteoporosis in Women Undergoing Surgical MenopauseK23AR054334 · NIAMS · EMORY UNIVERSITY · PI TANGPRICHA, VIN · 2007 to 2011
$641k
NCATS NIH HHS UL1 TR000454NCRR NIH HHS K24 RR023356NIAMS NIH HHS K23 AR054334NIAMS NIH HHS K23AR054334NIDDK NIH HHS 5T32DK007298NIDDK NIH HHS T32 DK007298
6 · The paper itself

Abstract

backgroundVitamin D insufficiency is common in hospitalized patients. Recent evidence suggests that vitamin D may enhance the innate immune response by induction of cathelicidin (LL-37), an endogenous antimicrobial peptide produced by macrophages and neutrophils. Thus, the relationship between vitamin D status and LL-37 production may be of importance for host immunity, but little data is available on this subject, especially in the setting of human sepsis syndrome and other critical illness.

methodsPlasma concentrations of 25-hydroxyvitamin D (25(OH)D), vitamin D binding protein (DBP) and LL-37 in critically ill adult subjects admitted to intensive care units (ICUs) with sepsis and without sepsis were compared to healthy controls.

resultsCritically ill subjects had significantly lower plasma 25(OH)D concentrations compared to healthy controls. Mean plasma LL-37 levels were significantly lower in critically ill subjects compared to healthy controls. Vitamin D binding protein levels in plasma were significantly lower in critically ill subjects with sepsis compared to critically ill subjects without sepsis. There was a significant positive association between circulating 25(OH)D and LL-37 levels.

conclusionThis study demonstrates an association between critical illness and lower 25(OH)D and DBP levels in critically ill patients as compared to healthy controls. It also establishes a positive association between vitamin D status and plasma LL-37, which suggests that systemic LL-37 levels may be regulated by vitamin D status. Optimal vitamin D status may be important for innate immunity especially in the setting of sepsis. Further invention studies to examine this association are warranted.

Indexed as

Intensive Care UnitsAntimicrobial Cationic PeptidesCase-Control StudiesCathelicidinsCritical IllnessDemographyFemaleHealthHumansMaleMiddle AgedSepsisVitamin DVitamin D-Binding Protein25-hydroxyvitamin DAntimicrobial Cationic PeptidesCathelicidinsVitamin DVitamin D-Binding Protein

Identifiers

PMID19389235
PMCPMC2684740
OpenAlexW2154408193

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.